79% buyers of institutions opening or closing positions this quarter
28 more new buyers than exits, ownership fell 22.73 percentage points vs the prior quarter, and 2 well-known fund managers in the top 25.
79% buyers of institutions opening or closing positions this quarter
157.9% institutional ownership
Sands Capital Alternatives, portfolio allocation
Institutional ownership vs Biotechnology peers
No Form 4 insider transactions on file
Latest positioning in IKT across 13F flow, ownership shift, marquee holders, and holder-count growth.
Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in IKT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | 13.0M | $21.9M | 0.0% | 18.336% | 5.19% |
| 2 | Soleus Capital Management, L.P. | 10.9M | $18.3M | 0.0% | 15.316% | 0.74% |
| 3 | Fairmount Funds Management LLC | 8.6M | $14.5M | 0.0% | 12.147% | 1.05% |
| 4 | Trails Edge Capital Partners, LP | 8.1M | $13.5M | +30.4% | 11.348% | 3.10% |
| 5 | ADAR1 Capital Management, LLC | 6.6M | $11.1M | -18.1% | 9.305% | 0.65% |
| 6 | BlackRock, Inc. | 6.3M | $10.6M | +90.7% | 8.878% | 0.00% |
| 7 | Blackstone Inc | 5.9M | $10.0M | 0.0% | 8.363% | 0.04% |
| 8 | Siren, L.L.C. | 5.8M | $9.8M | 0.0% | 8.239% | 0.27% |
| 9 | COMMODORE CAPITAL LP | 5.4M | $9.1M | 0.0% | 7.602% | 0.52% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $7.5M | — | 6.268% | 0.00% |
| 11 | Saturn V Capital Management LP | 3.9M | $6.5M | +0.2% | 5.441% | 1.18% |
| 12 | Spruce Street Capital LP | 3.6M | $6.0M | 0.0% | 5.044% | 1.45% |
| 13 | Squadron Capital Management LLC | 3.5M | $5.9M | -17.2% | 4.929% | 2.15% |
| 14 | MILLENNIUM MANAGEMENT LLC | 2.9M | $4.9M | +1623.9% | 4.124% | 0.00% |
| 15 | Nantahala Capital Management, LLC | 2.7M | $4.5M | -31.2% | 3.805% | 0.17% |
| 16 | Kalehua Capital Management LLC | 2.7M | $4.5M | +52.7% | 3.764% | 3.79% |
| 17 | PERCEPTIVE ADVISORS LLC | 2.3M | $3.9M | -57.3% | 3.260% | 0.08% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $3.6M | +92.3% | 3.056% | 0.00% |
| 19 | STATE STREET CORP | 1.7M | $2.8M | +203.8% | 2.374% | 0.00% |
| 20 | SummitTX Capital, L.P. | 1.5M | $2.6M | — | 2.147% | 0.08% |
| 21 | Integral Health Asset Management, LLC | 1.4M | $2.3M | -22.9% | 1.901% | 0.11% |
| 22 | Ally Bridge Group (NY) LLC | 1.3M | $2.2M | — | 1.866% | 1.80% |
| 23 | CITADEL ADVISORS LLC | 1.1M | $1.9M | -11.3% | 1.553% | 0.00% |
| 24 | Stonepine Capital Management, LLC | 957K | $1.6M | -59.2% | 1.348% | 0.64% |
| 25 | TWO SIGMA INVESTMENTS, LP | 848K | $1.4M | — | 1.194% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in IKT — a direct measure of their conviction.
Filings activity in IKT during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new IKT position in Q1 2026
Institutions that fully closed their IKT position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 102 | +38% | 157.89% | 22.73 pp | $191M | 13% |
| Q4 2025 | 74 | +37% | 180.62% | +106.91 pp | $218M | +145% |
| Q3 2025 | 54 | +10% | 73.71% | 14.03 pp | $89M | 16% |
| Q2 2025 | 49 | +2.1% | 87.74% | 5.30 pp | $106M | 5.7% |
| Q1 2025 | 48 | +50% | 93.04% | 41.39 pp | $112M | 31% |
| Q4 2024 | 32 | +167% | 134.43% | +133.50 pp | $162M | +14410% |
| Q3 2024 | 12 | 7.7% | 0.93% | +0.08 pp | $1M | +9.5% |
| Q2 2024 | 13 | — | 0.85% | — | $1M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
No recent Form 4 insider transactions on file for IKT.
Quick answers to the most common questions about buying IKT stock.
Based on Q1 2026 13F filings, institutional ownership of Inhibikase Therapeutics, Inc. stands at 157.9%, held across 102 reporting institutions.
Sands Capital Alternatives, LLC is the largest reported institutional holder of IKT, with approximately 13,018,965 shares worth $0.02B as of Q1 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of IKT, including CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for IKT is 52 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
38 institutions opened new positions in IKT during Q1 2026, while 10 fully exited. 30 added to existing positions and 33 trimmed.
IKT institutional ownership fell by 22.73 percentage points quarter-over-quarter, with a net change of — holders.
The top 10 institutions account for 66.2% of all reported 13F value in IKT, and the top 25 account for 94.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.